Cargando…

Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis

BACKGROUND: Optical coherence tomography (OCT) is a sensitive method for quantifying retinal neuronal and axonal structures. Reductions in retinal nerve fiber layer (RNFL) and ganglion cell inner plexiform layer (GCIPL) thicknesses have a reported association with white and grey matter atrophy in mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dreyer-Alster, Sapir, Gal, Aviva, Achiron, Anat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Neuro-Ophthalmology 2022
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834165/ https://www.ncbi.nlm.nih.gov/pubmed/34294657 http://dx.doi.org/10.1097/WNO.0000000000001326

Ejemplares similares

Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a
por: Menascu, Shay, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis
por: Menascu, Shay, et al.
Publicado: (2023)

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod
por: Achiron, Anat, et al.
Publicado: (2022)

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Achiron, Anat, et al.
Publicado: (2021)

Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?
por: Achiron, Anat, et al.
Publicado: (2021)

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects
por: Achiron, Anat, et al.
Publicado: (2021)

In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
por: Achiron, Anat, et al.
Publicado: (2023)

Prefrontal hemodynamics during forward and backward walking, with and without a cognitive task, in people with multiple sclerosis
por: KUPCHENKO, Yana, et al.
Publicado: (2023)

Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
por: Chalkias, Ioannis-Nikolaos, et al.
Publicado: (2022)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Achiron, Anat, et al.
Publicado: (2021)

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
por: Achiron, Anat, et al.
Publicado: (2021)

Longitudinal relationships between disability and gait characteristics in people with MS
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis
por: Cerdá-Fuertes, Nuria, et al.
Publicado: (2023)

Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis
por: Murphy, Olwen C., et al.
Publicado: (2020)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
por: Achiron, Anat, et al.
Publicado: (2021)

Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study
por: Masala, Alessandro, et al.
Publicado: (2022)

Quantifying Gait Impairment Using an Instrumented Treadmill in People with Multiple Sclerosis
por: Kalron, Alon, et al.
Publicado: (2013)

Visual Function and Brief Cognitive Assessment for Multiple Sclerosis in Optic Neuritis Clinically Isolated Syndrome Patients
por: Collorone, Sara, et al.
Publicado: (2022)

Optical coherence tomography for retinal imaging in multiple sclerosis
por: Zimmermann, Hanna, et al.
Publicado: (2014)

Evaluation of optical coherence tomography angiography findings in patients with multiple sclerosis
por: Khader, Sarah A, et al.
Publicado: (2021)

Optimizing multiple sclerosis diagnosis: gene expression and genomic association
por: Gurevich, Michael, et al.
Publicado: (2015)

Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An Update
por: Noval, Susana, et al.
Publicado: (2011)

Angiography with optical coherence tomography as a biomarker in multiple sclerosis
por: Cordon, Beatriz, et al.
Publicado: (2020)

Optical coherence tomography versus visual evoked potential in multiple sclerosis patients
por: Fatehi, Farzad, et al.
Publicado: (2012)

Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis
por: Grecescu, M
Publicado: (2014)

Machine learning classification of multiple sclerosis in children using optical coherence tomography
por: Ciftci Kavaklioglu, Beyza, et al.
Publicado: (2022)

Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis?
por: Costello, Fiona, et al.
Publicado: (2018)

Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis
por: Mehmood, Arshad, et al.
Publicado: (2021)

Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study
por: Masala, Alessandro, et al.
Publicado: (2022)

Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects
por: Olbert, Elisabeth, et al.
Publicado: (2022)

Identifying Optical Coherence Tomography Markers for Multiple Sclerosis Diagnosis and Management
por: Cujba, Larisa, et al.
Publicado: (2023)

Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran
por: Talebi, Mahnaz, et al.
Publicado: (2013)

Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study
por: Achiron, Anat, et al.
Publicado: (2013)

Can Blood Gene Expression Predict Which Patients with Multiple Sclerosis Will Respond to Interferon?
por: Kaminski, Naftali, et al.
Publicado: (2005)

Clinically Isolated Syndromes Suggestive of Multiple Sclerosis: An Optical Coherence Tomography Study
por: Oreja-Guevara, Celia, et al.
Publicado: (2012)

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
por: Bennett, JL, et al.
Publicado: (2015)

Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study
por: Farci, Roberta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4plsdn0qigceddsrvs7tgirjo7